Durham’s BioAgilytix partners with Boston firm to help employers test for COVID-19Date Published:
RESEARCH TRIANGLE PARK – Durham based BioAgilytix Labs has partnered with Boston’s Brio Systems to launch a platform to provide U.S. employers comprehensive COVID-19 testing programs.
BioAgilytix, a bioanalytical laboratory with a diagnostic testing division, said the launch of the product, dubbed COVIDence, offers a one-stop solution to manage employee testing and mitigate exposure within workforces.
The service supported by BRIO Systems covers all procedural aspects: sample collection logistics, testing, results reporting for employers and guides effective COVID-19-related risk mitigation strategies.
Brio Systems offers a platform that is designed to expand access to COVID-19 testing and guide risk mitigation strategies. The company’s logistics infrastructure creates a one-stop solution to manage employee testing in conjunction with BioAgilytix Labs’ testing. Both companies advise and oversee the process and ensure the process maximizes business requirements, workplace dynamics, and state-specific regulations.
BioAgilytix uses FDA Emergency Use Authorization-approved, PCR-based TaqPath to perform viral and antibody testing to identify active COVID-19 infection. Individuals who have developed antibodies from past exposure can be detected through the Roche cobas Elecys Anti-SARS-CoC-2 serology test. Both test results will made available to the employer within 48 hours of receipt. Brio’s online portal allows 100% digital workflow and is HIPAA-compliant.
COVIDence specialists can send participating employers sample-collection kits, or send qualified health professionals to collect samples on-site. Mailers are provided to employers and come pre-labeled with postage paid to send to BioAgilytix’s lab.
With laboratory locations in Durhanm, the Cambridge area of Massachusetts, and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across numerous industries and disease states.
BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e. product release testing, stability testing, etc.). BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory.
BRIO offers a complete COVID-19 testing system to help employers keep teams safe and businesses on track. The platform encompasses access to lab-backed PCR and antibody testing, full logistics to guide employers through the testing process, comprehensive medical oversight, and secure digital results communication within three days of test collection.
(C) N.C. Biotech Center
Original Article Source: WRAL TechWire